While Tarsus Pharmaceuticals Inc has overperformed by 2.22%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, TARS rose by 115.41%, with highs and lows ranging from $42.50 to $12.57, whereas the simple moving average jumped by 17.14% in the last 200 days.
On November 20, 2023, Goldman started tracking Tarsus Pharmaceuticals Inc (NASDAQ: TARS) recommending Neutral. A report published by William Blair on July 18, 2023, Initiated its previous ‘Outperform’ rating for TARS. Barclays Initiated an Overweight rating on August 01, 2022, and assigned a price target of $40. H.C. Wainwright initiated its ‘Buy’ rating for TARS, as published in its report on December 21, 2021. Oppenheimer’s report from November 23, 2021 suggests a price prediction of $55 for TARS shares, giving the stock a ‘Outperform’ rating. Raymond James also rated the stock as ‘Strong Buy’.
Analysis of Tarsus Pharmaceuticals Inc (TARS)
In order to gain a clear picture of Tarsus Pharmaceuticals Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -75.04% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 6.99, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 703.03K can be a very valuable indicator of volatility for TARS stock. On a monthly basis, the volatility of the stock is set at 5.28%, whereas on a weekly basis, it is put at 5.29%, with a gain of 10.01% over the past seven days. Furthermore, long-term investors anticipate a median target price of $59.00, showing growth from the present price of $35.50, which can serve as yet another indication of whether TARS is worth investing in or should be passed over.
How Do You Analyze Tarsus Pharmaceuticals Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 16.43%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 98.93% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
TARS shares are owned by institutional investors to the tune of 98.93% at present.
